Catalyst Wire Dossier Catalyst Wire Dossier

Bupivacaine Spinal

Bupivacaine hydrochloride in dextrose · Hospira, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Bupivacaine Spinal, covering 2010-04-07 to 2020-06-09. Get the full timeline:

Most recent: FDA Approved: BUPIVACAINE SPINAL — Supplemental Application (Hospira, Inc.)

See pricing